Stefania Scala
Stefania Scala
Oncology- Immunology
Email verificata su
Citata da
Citata da
Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
Z Liang, H Wu, J Xia, Y Li, Y Zhang, K Huang, N Wagar, Y Yoon, HT Cho, ...
Biochemical pharmacology 79 (6), 817-824, 2010
Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma
S Scala, A Ottaiano, PA Ascierto, M Cavalli, E Simeone, P Giuliano, ...
Clinical Cancer Research 11 (5), 1835-1841, 2005
Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies
PA Ascierto, S Scala, G Castello, A Daponte, E Simeone, A Ottaiano, ...
Journal of Clinical Oncology 23 (30), 7660-7668, 2005
Molecular pathways: targeting the CXCR4–CXCL12 axis—untapped potential in the tumor microenvironment
S Scala
Clinical cancer research 21 (19), 4278-4285, 2015
P-glycoprotein substrates and antagonists cluster into two distinct groups
S Scala, N Akhmed, US Rao, K Paull, LB Lan, B Dickstein, JS Lee, ...
Molecular Pharmacology 51 (6), 1024-1033, 1997
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients
A Ottaiano, R Franco, A Aiello Talamanca, G Liguori, F Tatangelo, ...
Clinical cancer research 12 (9), 2795-2803, 2006
HCV-related hepatocellular carcinoma: From chronic inflammation to cancer
G Castello, S Scala, G Palmieri, SA Curley, F Izzo
Clinical immunology 134 (3), 237-250, 2010
Adenovirus-mediated suppression of HMGI (Y) protein synthesis as potential therapy of human malignant neoplasias
S Scala, G Portella, M Fedele, G Chiappetta, A Fusco
Proceedings of the National Academy of Sciences 97 (8), 4256-4261, 2000
Human melanoma metastases express functional CXCR4
S Scala, P Giuliano, PA Ascierto, C Ieranò, R Franco, M Napolitano, ...
Clinical cancer research 12 (8), 2427-2433, 2006
Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion
C D’Alterio, S Scala, G Sozzi, L Roz, G Bertolini
Seminars in cancer biology 60, 351-361, 2020
Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P‐glycoprotein or MRP overexpression
JS Lee, S Scala, Y Matsumoto, B Dickstein, R Robey, Z Zhan, G Altenberg, ...
Journal of cellular biochemistry 65 (4), 513-526, 1997
Cystic fibrosis transmembrane conductance regulator and adenosine triphosphate
EH Abraham, P Okunieff, S Scala, P Vos, MJS Oosterveld, AY Chen, ...
Science 275 (5304), 1324-1326, 1997
Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts
M Fedele, MT Berlingieri, S Scala, L Chiariotti, G Viglietto, V Rippel, ...
Oncogene 17 (4), 413-418, 1998
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated endometrial cancers: new candidates for checkpoint blockade immunotherapy?
P Gargiulo, C Della Pepa, S Berardi, D Califano, S Scala, L Buonaguro, ...
Cancer treatment reviews 48, 61-68, 2016
Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells
A Ottaiano, A di Palma, M Napolitano, C Pisano, S Pignata, F Tatangelo, ...
Cancer Immunology, Immunotherapy 54, 781-791, 2005
Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
M Cioffi, C D’Alterio, R Camerlingo, V Tirino, C Consales, A Riccio, ...
Scientific reports 5 (1), 10357, 2015
Detection, monitoring, and management of trastuzumab‐induced left ventricular dysfunction: an actual challenge
CG Tocchetti, G Ragone, C Coppola, D Rea, G Piscopo, S Scala, ...
European journal of heart failure 14 (2), 130-137, 2012
Prostate cancer detection in the “grey area” of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun’s nomogram, two risk…
S Perdona, V Cavadas, G Di Lorenzo, R Damiano, G Chiappetta, ...
European urology 59 (1), 81-87, 2011
Critical role of the HMGI (Y) proteins in adipocytic cell growth and differentiation
RM Melillo, GM Pierantoni, S Scala, S Battista, M Fedele, A Stella, ...
Molecular and cellular biology 21 (7), 2485-2495, 2001
Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer
C D'alterio, C Consales, M Polimeno, R Franco, L Cindolo, L Portella, ...
Current cancer drug targets 10 (7), 772-781, 2010
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20